Clinical applications of preimplantation genetic testing

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Brezina, Paul R ^a,b   Kutteh, William H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fertility Associates of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; BLASTOCYST; CHROMOSOME ANALYSIS; CHROMOSOME PAIRING; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EFFECT SIZE; EMBRYO CELL; EMBRYO CULTURE; EMBRYO DEVELOPMENT; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC DISORDER; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; INCIDENCE; MEDICAL EXPERT; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; PRACTICE GUIDELINE; PREIMPLANTATION EMBRYO; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STRUCTURAL CHROMOSOME ABERRATION; CHROMOSOME DISORDERS; ETHICS; MEDICAL ETHICS; PROCEDURES;

CHROMOSOME DISORDERS; ETHICS, MEDICAL; GENETIC TESTING; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREIMPLANTATION DIAGNOSIS;

EID: 84923869716     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7611     Document Type: Review

References (129)

1. Brezina PR, Benner A, Rechitsky S, Kuliev A, Pomerantseva E, Pauling D, et al. Single-gene testing combined with single nucleotide polymorphism microarray preimplantation genetic diagnosis for aneuploidy: a novel approach in optimizing pregnancy outcome. Fertil Steril 2011;95:1786.e5-8.
2. Brezina PR, Brezina DS, Kearns WG. Preimplantation genetic testing. BMJ 2012;345:e5908.
3. Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J, et al. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod 2011;26:33-40.
4. Ginsburg ES, Baker VL, Racowsky C, Wantman E, Goldfarb J, Stern JE. Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology writing group paper. Fertil Steril 2011;96:865-8.
5. Brezina PR, Kearns WG. The evolving role of genetics in reproductive medicine. Obstet Gynecol Clin North Am 2014;41:41-55.
6. Shahine LK, Lathi RB. Embryo selection with preimplantation chromosomal screening in patients with recurrent pregnancy loss. Semin Reprod Med 2014;32:93-9.
7. Scott KL, Hong KH, Scott RT Jr. Selecting the optimal time to perform biopsy for preimplantation genetic testing. Fertil Steril 2013;100:608-14.
8. Forman EJ, Upham KM, Cheng M, Zhao T, Hong KH, Treff NR, et al. Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer. Fertil Steril 2013;100:718-24.
9. Berger VK, Baker VL. Preimplantation diagnosis for single gene disorders. Semin Reprod Med 2014;32:107-13.
10. Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta SB, et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update 2012;18:234-47.
11. Goossens V, Traeger-Synodinos J, Coonen E, De Rycke M, Moutou C, Pehlivan T, et al. ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009. Hum Reprod 2012;27:1887-911.
12. Moutou C, Goossens V, Coonen E, De Rycke M, Kokkali G, Renwick P, et al. ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010. Hum Reprod 2014;29:880-903.
13. SART CORS. Clinic summary report. Secondary clinic summary report 2014. www.sartcorsonline.com/rptCSR-PublicMultYear.aspx?ClinicPKID=0.
14. Brezina PR, Ke RW, Kutteh WH. Preimplantation genetic screening: a practical guide. Clin Med Insights Reprod Health 2013;7:37-42.
15. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990;344:768-70.
16. Zhao Y, Brezina P, Hsu CC, Garcia J, Brinsden PR, Wallach E. In vitro fertilization: four decades of reflections and promises. Biochim Biophys Acta 2011;1810:843-52.
17. Bodurtha J, Strauss JF 3rd. Genomics and perinatal care. N Engl J Med 2012;366:64-73.
18. Verlinsky Y, Rechitsky S, Evsikov S, White M, Cieslak J, Lifchez A, Preconception and preimplantation diagnosis for cystic fibrosis. Prenat Diagn 1992;12:103-10.
19. Kuliev A, Pakhalchuk T, Verlinsky O, Tur-Kaspa I, Kalakoutis G, Angastiniotis M, et al. Preimplantation genetic diagnosis for hemoglobinopathies. Hemoglobin 2011;35:547-55.
20. Verlinsky Y, Rechitsky S, Sharapova T, Laziuk K, Barsky I, Verlinsky O, et al. Preimplantation diagnosis for immunodeficiencies. Reprod Biomed Online 2007;14:214-23.
21. Verlinsky Y, Rechitsky S, Verlinsky O, Ozen S, Beck R, Kuliev A. Preimplantation genetic diagnosis for polycystic kidney disease. Fertil Steril 2004;82:926-9.
22. Hussey ND, Davis T, Hall JR, Barry MF, Draper R, Norman RJ, et al. Preimplantation genetic diagnosis for beta-thalassaemia using sequencing of single cell PCR products to detect mutations and polymorphic loci. Mol Hum Reprod 2002;8:1136-43.
23. Rechitsky S, Verlinsky O, Amet T, Rechitsky M, Kouliev T, Strom C, et al. Reliability of preimplantation diagnosis for single gene disorders. Mol Cell Endocrinol 2001;183(suppl 1):S65-8.
24. Janssens S, De Paepe A, Borry P. Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature. J Commun Genet 2014;5:13-29.
25. Van Rij MC, De Rademaeker M, Moutou C, Dreesen JC, De Rycke M, Liebaers, et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet 2012;20:368-75.
26. Verlinsky Y, Cohen J, Munne S, Gianaroli L, Simpson JL, Ferraretti AP, et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 2004;82:292-4.
27. Hattori M, Yoshioka K, Sakaki Y. High-sensitive fluorescent DNA sequencing and its application for detection and mass-screening of point mutations. Electrophoresis 1992;13:560-5.
28. Rechitsky S, Verlinsky O, Kuliev A. PGD for cystic fibrosis patients and couples at risk of an additional genetic disorder combined with 24-chromosome aneuploidy testing. Reprod Biomed Online 2013;26:420-30.
29. Altarescu G, Zeevi DA, Zeligson S, Perlberg S, Eldar-Geva T, Margalioth EJ, et al. Familial haplotyping and embryo analysis for preimplantation genetic diagnosis (PGD) using DNA microarrays: a proof of principle study. J Assist Reprod Genet 2013;30:1595-603.
30. Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med 2014;16:838-45.
31. Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod (Oxford) 2009;24:1221-8.
32. Harton G, Braude P, Lashwood A, Schmutzler A, Traeger-Synodinos J, Hilton L, et al. ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod (Oxford) 2011;26:14-24.
33. Laurie AD, Hill AM, Harraway JR, Fellowes AP, Phillipson GT, Benny PS, et al. Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches. J Thromb Haemost 2010;8:783-9.
34. Escudero T, Estop A, Fischer J, Munne S. Preimplantation genetic diagnosis for complex chromosome rearrangements. Am J Med Genet Part A 2008;146:1662-9.
35. Lim CK, Cho JW, Song IO, Kang IS, Yoon YD, Jun JH. Estimation of chromosomal imbalances in preimplantation embryos from preimplantation genetic diagnosis cycles of reciprocal translocations with or without acrocentric chromosomes. Fertil Steril 2008;90:2144-51.
36. Ko DS, Cho JW, Park SY, Kim JY, Koong MK, Song IO. Clinical outcomes of preimplantation genetic diagnosis (PGD) and analysis of meiotic segregation modes in reciprocal translocation carriers. Am J Med Genet Part A 2010;152:1428-33.
37. Bint SM, Ogilvie CM, Flinter FA, Khalaf Y, Scriven PN. Meiotic segregation of Robertsonian translocations ascertained in cleavage-stage embryos - implications for preimplantation genetic diagnosis. Hum Reprod (Oxford) 2011;26:1575-84.
38. Li G, Jin H, Xin Z, Brezina PR, Benner AT, Kearns WG, et al. Increased IVF pregnancy rates after microarray preimplantation genetic diagnosis due to parental translocations. Syst Biol Reprod Med 2014;60:119-24.
39. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012;98:1103-11.
40. Brezina PR, Kutteh WH. Classic and cutting-edge strategies for the management of early pregnancy loss. Obstet Gynecol Clin North Am 2014;41:1-18.
41. Scriven PN, Handyside AH, Ogilvie CM. Chromosome translocations: segregation modes and strategies for preimplantation genetic diagnosis. Prenat Diagn 1998;18:1437-49.
42. Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art 2011. Hum Genet 2012;131:175-86.
43. Harper JC, de Die-Smulders C, Goossens V, Harton G, Moutou C, Repping S. ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod (Oxford) 2008;23:741-55.
44. Bisignano A, Wells D, Harton G, Munne S. PGD and aneuploidy screening for 24 chromosomes: advantages and disadvantages of competing platforms. Reprod Biomed Online 2011;23:677-85.
45. Treff NR, Northrop LE, Kasabwala K, Su K, Levy B, Scott RT Jr. Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil Steril 2011;95:1606-12.e1-2.
46. Kuliev A, Rechitsky S, Verlinsky O, Tur-Kaspa I, Kalakoutis G, Angastiniotis M, et al. Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod Biomed Online 2005;11:362-70.
47. Verlinsky Y, Rechitsky S, Sharapova T, Morris R, Taranissi M, Kuliev A. Preimplantation HLA testing. JAMA 2004;291:2079-85.
48. Whittaker AM. Reproduction opportunists in the new global sex trade: PGD and non-medical sex selection. Reprod Biomed Online 2011;23:609-17.
49. Sharp RR, McGowan ML, Verma JA, Landy DC, McAdoo S, Carson SA, et al. Moral attitudes and beliefs among couples pursuing PGD for sex selection. Reprod Biomed Online 2010;21:838-47.
50. Macklin R. The ethics of sex selection and family balancing. Semin Reprod Med 2010;28:315-21.
51. Hollingsworth LD. Ethical considerations in prenatal sex selection. Health Social Work 2005;30:126-34.
52. Ethics Committee of the American Society for Reproductive Medicine. Preconception gender selection for nonmedical reasons. Fertil Steril 2004;82(1 suppl):S232-5.
53. Tuffs A. Germany allows restricted access to preimplantation genetic testing. BMJ 2011;343:d4425.
54. Harper JC, Geraedts J, Borry P, Cornel MC, Dondorp W, Gianaroli L, et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet 2013;21(suppl 2):S1-21.
55. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010;11:415-25.
56. Bredenoord A, Dondorp W, Pennings G, de Die-Smulders C, Smeets B, de Wert G. Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice. Eur J Hum Genet 2009;17:1550-9.
57. Walsh S, Liu F, Wollstein A, Kovatsi L, Ralf A, Kosiniak-Kamysz A, Branicki W, et al. The HIrisPlex system for simultaneous prediction of hair and eye colour from DNA. Forens Sci Int Genet 2013;7:98-115.
58. Branicki W, Liu F, van Duijn K, Draus-Barini J, Pospiech E, Walsh S, et al. Model-based prediction of human hair color using DNA variants. Hum Genet 2011;129:443-54.
59. st century: uncharted territory. Clin Med Insights Reprod Health 2013;7:17-21.
60. Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, de Mouzon J, Castilla JA, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod (Oxford) 2013;28:2318-31.
61. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC. ESHRE PGD Consortium/Embryology Special Interest Group - best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod (Oxford) 2011;26:41-6.
62. ACOG Committee. Opinion no 430: preimplantation genetic screening for aneuploidy. Obstet Gynecol 2009;113:766-7.
63. Brezina PR, Zhao Y. The ethical, legal, and social issues impacted by modern assisted reproductive technologies. Obstet Gynecol Int 2012;2012:686253.
64. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 2013;15:482-3.
65. Ross LF. A re-examination of the use of ethnicity in prenatal carrier testing. Am J Med Genet Part A 2012;158:19-23.
66. ACOG Committee. Opinion no 486: update on carrier screening for cystic fibrosis. Obstet Gynecol 2011;117:1028-31.
67. Harper J, Coonen E, De Rycke M, Fiorentino F, Garaedts J, Goosens V, et al. What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium steering committee. Hum Reprod (Oxford) 2010;25:821-3.
68. Munne S, Weier HU, Grifo J, Cohen J. Chromosome mosaicism in human embryos. Biol Reprod 1994;51:373-9.
69. Colls P, Escudero T, Cekleniak N, Sadowy S, Cohen J, Munne S. Increased efficiency of preimplantation genetic diagnosis for infertility using "no result rescue." Fertil Steril 2007;88:53-61.
70. Burgoyne PS, Holland K, Stephens R. Incidence of numerical chromosome anomalies in human pregnancy estimation from induced and spontaneous abortion data. Hum Reprod (Oxford) 1991;6:555-65.
71. Hassold T, Chen N, Funkhouser J, Jooss T, Manuel B, Matsuura J, et al. A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 1980;44:151-78.
72. Kalousek DK, Pantzar T, Tsai M, Paradice B. Early spontaneous abortion: morphologic and karyotypic findings in 3912 cases. Birth Defects Original Article Series 1993;29:53-61.
73. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod (Oxford) 2002;17:446-51.
74. Forman EJ, Hong KH, Treff NR, Scott RT. Comprehensive chromosome screening and embryo selection: moving toward single euploid blastocyst transfer. Semin Reprod Med 2012;30:236-42.
75. Handyside AH. PGD and aneuploidy screening for 24 chromosomes by genome-wide SNP analysis: seeing the wood and the trees. Reprod Biomed Online 2011;23:686-91.
76. Wong KM, Repping S, Mastenbroek S. Limitations of embryo selection methods. Semin Reprod Med 2014;32:127-33.
77. Brezina PR, Tobler K, Benner AT, Du L, Xu X, Kearns WG. All 23 chromosomes have significant levels of aneuploidy in recurrent pregnancy loss couples. Fertil Steril 2012;97(3 suppl):S7.
78. Scott RT Jr, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril 2013;100:697-703.
79. Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012;5:24.
80. Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott RT Jr. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod (Oxford) 2012;27:1217-22.
81. Resetkova N, Tobler KJ, Kearns WG, Werner EF. In vitro fertilization (IVF) with 23-chromosome pair preimplantation genetic screening (PGS) is cost effective to achieve a live birth compared to IVF alone for recurrent pregnancy loss (RPL). Fertil Steril 2013;100(3 suppl):S99-100.
82. Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott RT Jr. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod 2010;16:583-9.
83. Gutierrez-Mateo C, Colls P, Sanchez-Garcia J, Escudero T, Prates R, Ketterson K. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011;95:953-8.
84. Wells D, Alfarawati S, Fragouli E. Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 2008;14:703-10.
85. Wells D, Levy B. Cytogenetics in reproductive medicine: the contribution of comparative genomic hybridization (CGH). Bioessays 2003;25:289-300.
86. Christianson MS, Brezina PR, Benner AT, Du L, Siegel A, Kearns WG. Chromosomal duplications (≥200 KILOBASES (KB)) are more common than deletions ≥200 KB in developing human embryos as identified by 23 chromosome single nucleotide polymorphism (SNP) microarray. Fertil Steril 2011;96(3 suppl):S21-2.
87. Chipko C, Brezina PR, Benner AT, Du L, Christianson MS, Kearns WG. Deletions and duplications identified by 23 chromosome single nucleotide polymorphism (SNP) microarray are associated with aneuploidy. Fertil Steril 2011;96(3 suppl):S21.
88. Schaaf CP, Scott DA, Wiszniewska J, Beaudet AL. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet 2011;377:555-6.
89. Brezina PR, Benner AT, Garcia J, Zhao Y, Handyside A, Kearns WG. Dense single nucleotide polymorphism (SNP) microarrays for the identification of aneuploidy and consanguinity in preimplantation embryos. Fertil Steril 2012;97(3 suppl):S24.
90. Tobler KJ, Brezina PR, Benner AT, Du XL, Kearns WG. Two different microarray technologies for preimplantation genetic diagnosis (PGD) and screening (PGS), due to reciprocal translocation imbalances, demonstrate equivalent clinical pregnancy rates. Fertil Steril 2013;100(3 suppl):S36.
91. Tobler KJ, Brezina PR, Benner AT, Du L, Boyd B, Kearns WG. 23-chromosome single nucleotide polymorphism (SNP) microarray preimplantation genetic screening (PGS) for recurrent pregnancy loss (RPL) in 687 in vitro fertilization (IVF) cycles and 5871 embryos. Fertil Steril 2012;98(3 suppl):S54.
92. Scott RT Jr, Ferry K, Su J, Tao X, Scott K, Treff NR. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 2012;97:870-5.
93. Handyside AH. 24-chromosome copy number analysis: a comparison of available technologies. Fertil Steril 2013;100:595-602.
94. Martin J, Cervero A, Mir P, Martinez-Conejero JA, Pellicer A, et al. The impact of next-generation sequencing technology on preimplantation genetic diagnosis and screening. Fertil Steril 2013;99:1054-61.e3.
95. Simpson JL, Rechitsky S, Kuliev A. Next-generation sequencing for preimplantation genetic diagnosis. Fertil Steril 2013;99:1203-4.
96. Treff NR, Forman EJ, Scott RT Jr. Next-generation sequencing for preimplantation genetic diagnosis. Fertil Steril 2013;99:e17-8.
97. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007;357:9-17.
98. Checa MA, Alonso-Coello P, Sola I, Robles A, Carreras R, Balasch J. IVF/ICSI with or without preimplantation genetic screening for aneuploidy in couples without genetic disorders: a systematic review and meta-analysis. J Assist Reprod Genet 2009;26:273-83.
99. Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011;17:454-66.
100. Scriven PN, Bossuyt PM. Diagnostic accuracy: theoretical models for preimplantation genetic testing of a single nucleus using the fluorescence in situ hybridization technique. Hum Reprod (Oxford) 2010;25:2622-8.
101. Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine. Preimplantation genetic testing: a practice committee opinion. Fertil Steril 2008;90(5 suppl):S136-43.
102. Scott RT Jr, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril 2013;100:624-30.
103. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod (Oxford) 2009;24:2988-96.
104. Dickey RP, Welch A, Carter J, Potts A, Brezina PR, Kearns WG. Embryo survival to blastocysts after cleavage stage biopsy. Fertil Steril 2013;100(3 suppl):S531-2.
105. Johnson DS, Cinnioglu C, Ross R, Filby A, Gemelos G, Hill M, et al. Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass. Mol Hum Reprod 2010;16:944-9.
106. Johnson DS, Gemelos G, Baner J, Ryan A, Cinnioglu C, Banjevic M, et al. Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (Oxford) 2010;25:1066-75.
107. Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med 2009;15:577-83.
108. Novik V, Moulton EB, Sisson ME, Shrestha SL, Tran KD, Stern JH, et al. The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts. Mol Cytogenet 2014;7:18.
109. Chuong FS, Tobler KJ, Brezina PR, Brenner AT, Du L, Xu X, et al. All 23 chromosome pairs demonstrate a risk of aneuploidy when performing preimplantation genetic screening (PGS) on differentiated blastocysts. Fertil Steril 2014;102(3 suppl):e174-5.
110. Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril 2010;94:1700-6.
111. Northrop LE, Treff NR, Levy B, Scott RT Jr. SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod 2010;16:590-600.
112. Hellani A, Abu-Amero K, Azouri J, El-Akoum S. Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening. Reprod Biomed Online 2008;17:841-7.
113. Treff NR, Su J, Tao X, Levy B, Scott RT Jr. Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril 2010;94:2017-21.
114. Kokkali G, Traeger-Synodinos J, Vrettou C, Vrettou C, Stavrou D, Jones GM, et al. Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study. Hum Reprod (Oxford) 2007;22:1443-9.
115. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet 2010;27:357-63.
116. Shapiro BS, Daneshmand ST, De Leon L, Garner FC, Aguirre M, Hudson C. Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy. Fertil Steril 2012;98:1490-4.
117. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil Steril 2011;96:516-8.
118. Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C. Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles. Fertil Steril 2013;99:389-92.
119. American Society for Reproductive Medicine. Elective single-embryo transfer. Fertil Steril 2012;97:835-42.
120. Fortunato A, Tosti E. The impact of in vitro fertilization on health of the children: an update. Eur J Obstet Gynecol Reprod Biol 2011;154:125-9.
121. Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in molecular genetic testing. Nat Rev Genet 2001;2:717-23.
122. Strom CM. Changing trends in laboratory testing in the United States: a personal, historical perspective. Clin Lab Med 2012;32:651-64.
123. Brezina PR, Ross R, Kaufmann R, Anchan R, Zhao Y, Kearns WG. Genetic normalization of differentiating aneuploid cleavage stage embryos. Fertil Steril 2013;100(3 suppl):S69.
124. Sakkas D. Embryo selection using metabolomics. Methods Mol Biol 2014;1154:533-40.
125. Uyar A, Seli E. Metabolomic assessment of embryo viability. Semin Reprod Med 2014;32:141-52.
126. Kirkegaard K, Svane AS, Nielsen JS, Hindkjær JJ, Nielsen NC, Ingerslev HJ. Nuclear magnetic resonance metabolomic profiling of Day 3 and 5 embryo culture medium does not predict pregnancy outcome in good prognosis patients: a prospective cohort study on single transferred embryos. Hum Reprod 2014;29:2413-20.
127. Ciray HN, Campbell A, Agerholm IE, Aguilar J, Chamayou S, Esbert M, et al Time-Lapse User Group. Proposed guidelines on the nomenclature and annotation of dynamic human embryo monitoring by a time-lapse user group. Hum Reprod 2014;29:2650-60)
128. Liu Y, Chapple V, Roberts P, Ali J, Matson P. Time-lapse videography of human oocytes following intracytoplasmic sperm injection: events up to the first cleavage division. Reprod Biol 2014;14:249-56.
129. Rubio I, Galán A, Larreategui Z, Ayerdi F, Bellver J, Herrero J, et al. Clinical validation of embryo culture and selection by morphokinetic analysis: a randomized, controlled trial of the EmbryoScope. Fertil Steril 2014;102:1287-94.e5